NCT05440786 2026-03-12CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's SarcomaEli Lilly and CompanyPhase 2 Active not recruiting46 enrolled 19 charts
NCT04238819 2026-03-02A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaEli Lilly and CompanyPhase 1/2 Completed47 enrolled 36 charts